We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$337M
AUM Growth
+$96.7M
Cap. Flow
+$69.8M
Cap. Flow %
20.69%
Top 10 Hldgs %
65.1%
Holding
137
New
22
Increased
54
Reduced
57
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 11.3%
2 Healthcare 11.2%
3 Consumer Staples 4.73%
4 Communication Services 3.09%
5 Materials 2.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$80.8B
$935K 0.28%
1,064
-4
-0.4% -$3.29K
VRTX icon
52
Vertex Pharmaceuticals
VRTX
$126B
$921K 0.27%
2,264
-44
-2% -$16.3K
HD icon
53
Home Depot
HD
$355B
$823K 0.24%
2,375
+111
+5% +$34.4K
DIS icon
54
Walt Disney
DIS
$181B
$780K 0.23%
8,635
-919
-10% -$81K
MRNA icon
55
Moderna
MRNA
$23.6B
$759K 0.23%
7,636
+1,882
+33% +$158K
T icon
56
AT&T
T
$163B
$755K 0.22%
44,988
-6,333
-12% -$100K
J icon
57
Jacobs Solutions
J
$17B
$731K 0.22%
6,805
-75
-1% -$8.16K
LH icon
58
Labcorp
LH
$25.9B
$717K 0.21%
3,156
+7
+0.2% +$1.47K
HPQ icon
59
HP
HPQ
$27.5B
$701K 0.21%
23,312
+1,984
+9% +$55.6K
BSX icon
60
Boston Scientific
BSX
$71.5B
$695K 0.21%
12,019
-1,081
-8% -$57.7K
JPM icon
61
JPMorgan Chase
JPM
$950B
$694K 0.21%
4,079
-132
-3% -$20K
ELV icon
62
Elevance Health
ELV
$85.5B
$629K 0.19%
1,334
-10
-0.7% -$4.62K
RWX icon
63
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
$628K 0.19%
+23,000
New +$567K
MET icon
64
MetLife
MET
$62.1B
$623K 0.18%
9,424
-101
-1% -$6.32K
IBB icon
65
iShares Biotechnology ETF
IBB
$9.77B
$611K 0.18%
+4,500
New +$549K
CI icon
66
Cigna
CI
$74.6B
$599K 0.18%
2,001
-63
-3% -$18.4K
DGX icon
67
Quest Diagnostics
DGX
$26.3B
$593K 0.18%
4,301
-80
-2% -$10.5K
MCK icon
68
McKesson
MCK
$101B
$563K 0.17%
1,216
-94
-7% -$42.7K
TMUS icon
69
T-Mobile US
TMUS
$190B
$560K 0.17%
3,491
-322
-8% -$47.6K
BAX icon
70
Baxter International
BAX
$14.2B
$531K 0.16%
13,745
+2,019
+17% +$71.4K
BIIB icon
71
Biogen
BIIB
$30.7B
$502K 0.15%
1,940
+346
+22% +$85K
MDLZ icon
72
Mondelez International
MDLZ
$79.9B
$497K 0.15%
6,860
-3
-0% -$206
ABT icon
73
Abbott
ABT
$187B
$485K 0.14%
4,404
+131
+3% +$13.1K
LOW icon
74
Lowe's Companies
LOW
$125B
$480K 0.14%
2,157
+138
+7% +$28K
DD icon
75
DuPont de Nemours
DD
$19.2B
$478K 0.14%
4,947
+287
+6% +$26.1K

Similar funds

Humankind Investments's Q4 2023 Portfolio in Review

As of Q4 2023, Humankind Investments held 137 positions worth $337M, up 40% from $240M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Humankind Investments deployed $69.8M of net new capital in Q4 2023, opening 22 new positions and adding to 54 existing holdings. Its largest new stake was Vanguard Total World Stock ETF: 101,000 shares worth $10.4M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Microsoft, an estimated $842K trimmed.

  • Humankind Investments's largest Q4 2023 buy was Vanguard Total World Stock ETF: 101,000 shares worth $10.4M.
  • Humankind Investments added most to Invesco QQQ Trust in Q4 2023, an estimated $13.6M increase.
  • Humankind Investments's biggest Q4 2023 reduction was Microsoft, cutting an estimated $842K.
  • Humankind Investments fully exited Sony in Q4 2023, selling an estimated $3.33M.
  • Humankind Investments's ten largest holdings make up 65% of its $337M portfolio in Q4 2023.
  • Humankind Investments opened 22 new positions and closed 2 in Q4 2023.
  • Humankind Investments's portfolio value rose 40% quarter-over-quarter to $337M.

Based on Humankind Investments's 13F filing for Q4 2023, filed 14 Feb 2024.